Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2000

View Archived Issues

Pharmos presents positive results from head trauma trial

MorphoSys and ImmunoGen begin human antibodies alliance

Alza to acquire Crescendo

Coulter obtains rights to technology related to RA treatment

Novo Nordisk's liquid Norditropin now available in U.S.

FDA approves breath-activated device with corticosteroid for asthma

Health Canada allows extension of paclitaxel trial for MS

IND filed by Endovasc for Liprostin

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Pain Therapeutics reports promising phase II clinical trial results for new pain treatment

Oncolytic compound shows promise as cytomegalovirus therapy

Novel neuregulin polypeptide which promotes neuronal survival or growth

Antimalarial antibodies designed at EntreMed

Vascular-damaging combretastatin derivatives and their use in treating tumors

Synthesis and activity of phenyl pyrrolidinone glutamate antagonists described by Eisai

More potential GH secretagogues patented by Lilly

Lilly describes new series acting on the serotonergic system

Cathepsin inhibitors claimed by AstraZeneca for use in COPD

SB presents cathepsin K inhibitors and their use

New cyclic amide compounds synthesized at Japanese lab act as selective M3 antagonists

Intranasal IM-862 enters phase III

First prescription drug to treat unwanted facial hair introduced in U.S.

New antiretroviral treatment option available from Abbott

New inhibitor of cathepsin K and bone resorption reduces bone turnover in primate model

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Beneficial effects of Ro-26-9228 on bone coupled with minimal effects on Ca homeostasis

Dual MMP/TACE inhibitor provides significant neuroprotection in bacterial meningitis

Final analysis of ISIS-2302 sparks reinitiation of development

New azasordarins characterized in several ICAAC presentations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...